nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Myocardial infarction—Vinblastine—lung cancer	0.0062	0.00625	CcSEcCtD
Metipranolol—Acute coronary syndrome—Erlotinib—lung cancer	0.00599	0.00604	CcSEcCtD
Metipranolol—Myocardial infarction—Erlotinib—lung cancer	0.00596	0.006	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00595	0.00599	CcSEcCtD
Metipranolol—Conjunctivitis—Erlotinib—lung cancer	0.00591	0.00595	CcSEcCtD
Metipranolol—Dyspnoea—Pemetrexed—lung cancer	0.00582	0.00586	CcSEcCtD
Metipranolol—Lacrimation increased—Docetaxel—lung cancer	0.00581	0.00586	CcSEcCtD
Metipranolol—Epistaxis—Topotecan—lung cancer	0.00579	0.00584	CcSEcCtD
Metipranolol—Dyspnoea—Gefitinib—lung cancer	0.00578	0.00583	CcSEcCtD
Metipranolol—Angina pectoris—Vinorelbine—lung cancer	0.00574	0.00579	CcSEcCtD
Metipranolol—Epistaxis—Erlotinib—lung cancer	0.00573	0.00578	CcSEcCtD
Metipranolol—Lacrimation—Doxorubicin—lung cancer	0.00568	0.00573	CcSEcCtD
Metipranolol—Hypertension—Teniposide—lung cancer	0.00559	0.00564	CcSEcCtD
Metipranolol—Rhinitis—Topotecan—lung cancer	0.00553	0.00557	CcSEcCtD
Metipranolol—Abnormal vision—Paclitaxel—lung cancer	0.00551	0.00555	CcSEcCtD
Metipranolol—Oedema—Teniposide—lung cancer	0.00529	0.00533	CcSEcCtD
Metipranolol—Acute coronary syndrome—Vinorelbine—lung cancer	0.00518	0.00522	CcSEcCtD
Metipranolol—Myocardial infarction—Vinorelbine—lung cancer	0.00515	0.00519	CcSEcCtD
Metipranolol—Asthenia—Crizotinib—lung cancer	0.00512	0.00516	CcSEcCtD
Metipranolol—Atrial fibrillation—Paclitaxel—lung cancer	0.00484	0.00488	CcSEcCtD
Metipranolol—Hypersensitivity—Pemetrexed—lung cancer	0.00481	0.00485	CcSEcCtD
Metipranolol—Hypersensitivity—Gefitinib—lung cancer	0.00478	0.00482	CcSEcCtD
Metipranolol—Angina pectoris—Irinotecan—lung cancer	0.00473	0.00477	CcSEcCtD
Metipranolol—Dizziness—Crizotinib—lung cancer	0.00472	0.00476	CcSEcCtD
Metipranolol—Dyspnoea—Teniposide—lung cancer	0.00471	0.00475	CcSEcCtD
Metipranolol—Asthenia—Pemetrexed—lung cancer	0.00468	0.00472	CcSEcCtD
Metipranolol—Asthenia—Gefitinib—lung cancer	0.00465	0.00469	CcSEcCtD
Metipranolol—Rash—Crizotinib—lung cancer	0.0045	0.00454	CcSEcCtD
Metipranolol—Dermatitis—Crizotinib—lung cancer	0.0045	0.00453	CcSEcCtD
Metipranolol—Dizziness—Pemetrexed—lung cancer	0.00432	0.00435	CcSEcCtD
Metipranolol—Acute coronary syndrome—Irinotecan—lung cancer	0.00427	0.00431	CcSEcCtD
Metipranolol—Hypertension—Vinblastine—lung cancer	0.00427	0.0043	CcSEcCtD
Metipranolol—Myocardial infarction—Irinotecan—lung cancer	0.00425	0.00428	CcSEcCtD
Metipranolol—Nausea—Crizotinib—lung cancer	0.00424	0.00428	CcSEcCtD
Metipranolol—Cough—Topotecan—lung cancer	0.00419	0.00422	CcSEcCtD
Metipranolol—Acute coronary syndrome—Gemcitabine—lung cancer	0.00416	0.00419	CcSEcCtD
Metipranolol—Discomfort—Vinblastine—lung cancer	0.00416	0.00419	CcSEcCtD
Metipranolol—Cough—Erlotinib—lung cancer	0.00414	0.00418	CcSEcCtD
Metipranolol—Myocardial infarction—Gemcitabine—lung cancer	0.00414	0.00417	CcSEcCtD
Metipranolol—Rash—Pemetrexed—lung cancer	0.00411	0.00415	CcSEcCtD
Metipranolol—Dermatitis—Pemetrexed—lung cancer	0.00411	0.00414	CcSEcCtD
Metipranolol—Atrial fibrillation—Docetaxel—lung cancer	0.0041	0.00413	CcSEcCtD
Metipranolol—Rash—Gefitinib—lung cancer	0.00409	0.00412	CcSEcCtD
Metipranolol—Myalgia—Topotecan—lung cancer	0.00409	0.00412	CcSEcCtD
Metipranolol—Dermatitis—Gefitinib—lung cancer	0.00408	0.00412	CcSEcCtD
Metipranolol—Myalgia—Erlotinib—lung cancer	0.00404	0.00408	CcSEcCtD
Metipranolol—Discomfort—Topotecan—lung cancer	0.00404	0.00407	CcSEcCtD
Metipranolol—Anxiety—Erlotinib—lung cancer	0.00403	0.00406	CcSEcCtD
Metipranolol—Bradycardia—Irinotecan—lung cancer	0.00396	0.00399	CcSEcCtD
Metipranolol—Rhinitis—Irinotecan—lung cancer	0.0039	0.00393	CcSEcCtD
Metipranolol—Hypersensitivity—Teniposide—lung cancer	0.00389	0.00393	CcSEcCtD
Metipranolol—Acute coronary syndrome—Cisplatin—lung cancer	0.00388	0.00391	CcSEcCtD
Metipranolol—Oedema—Erlotinib—lung cancer	0.00388	0.00391	CcSEcCtD
Metipranolol—Nausea—Pemetrexed—lung cancer	0.00388	0.00391	CcSEcCtD
Metipranolol—Myocardial infarction—Cisplatin—lung cancer	0.00386	0.00389	CcSEcCtD
Metipranolol—Nausea—Gefitinib—lung cancer	0.00385	0.00388	CcSEcCtD
Metipranolol—Conjunctivitis—Cisplatin—lung cancer	0.00382	0.00386	CcSEcCtD
Metipranolol—Bronchitis—Paclitaxel—lung cancer	0.00381	0.00384	CcSEcCtD
Metipranolol—Rhinitis—Gemcitabine—lung cancer	0.0038	0.00383	CcSEcCtD
Metipranolol—Asthenia—Teniposide—lung cancer	0.00379	0.00382	CcSEcCtD
Metipranolol—Visual impairment—Irinotecan—lung cancer	0.00375	0.00378	CcSEcCtD
Metipranolol—Palpitations—Vinorelbine—lung cancer	0.00363	0.00366	CcSEcCtD
Metipranolol—Lacrimation increased—Doxorubicin—lung cancer	0.00363	0.00366	CcSEcCtD
Metipranolol—Bradycardia—Cisplatin—lung cancer	0.0036	0.00362	CcSEcCtD
Metipranolol—Cough—Vinorelbine—lung cancer	0.00358	0.00361	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Topotecan—lung cancer	0.00357	0.0036	CcSEcCtD
Metipranolol—Acute coronary syndrome—Etoposide—lung cancer	0.00355	0.00358	CcSEcCtD
Metipranolol—Hypertension—Vinorelbine—lung cancer	0.00355	0.00357	CcSEcCtD
Metipranolol—Myocardial infarction—Etoposide—lung cancer	0.00353	0.00356	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00353	0.00356	CcSEcCtD
Metipranolol—Myalgia—Vinorelbine—lung cancer	0.0035	0.00352	CcSEcCtD
Metipranolol—Dyspnoea—Topotecan—lung cancer	0.00349	0.00352	CcSEcCtD
Metipranolol—Acute coronary syndrome—Paclitaxel—lung cancer	0.00348	0.00351	CcSEcCtD
Metipranolol—Myocardial infarction—Paclitaxel—lung cancer	0.00346	0.00349	CcSEcCtD
Metipranolol—Dyspnoea—Erlotinib—lung cancer	0.00346	0.00348	CcSEcCtD
Metipranolol—Discomfort—Vinorelbine—lung cancer	0.00345	0.00348	CcSEcCtD
Metipranolol—Conjunctivitis—Paclitaxel—lung cancer	0.00344	0.00346	CcSEcCtD
Metipranolol—Visual impairment—Cisplatin—lung cancer	0.0034	0.00343	CcSEcCtD
Metipranolol—Epistaxis—Paclitaxel—lung cancer	0.00333	0.00336	CcSEcCtD
Metipranolol—Rash—Teniposide—lung cancer	0.00333	0.00336	CcSEcCtD
Metipranolol—Dermatitis—Teniposide—lung cancer	0.00333	0.00336	CcSEcCtD
Metipranolol—Headache—Teniposide—lung cancer	0.00331	0.00334	CcSEcCtD
Metipranolol—Angina pectoris—Docetaxel—lung cancer	0.00327	0.0033	CcSEcCtD
Metipranolol—Bradycardia—Paclitaxel—lung cancer	0.00323	0.00326	CcSEcCtD
Metipranolol—Rhinitis—Paclitaxel—lung cancer	0.00318	0.00321	CcSEcCtD
Metipranolol—Nausea—Teniposide—lung cancer	0.00314	0.00316	CcSEcCtD
Metipranolol—Visual impairment—Paclitaxel—lung cancer	0.00306	0.00308	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00305	0.00308	CcSEcCtD
Metipranolol—Dyspnoea—Vinorelbine—lung cancer	0.00299	0.00301	CcSEcCtD
Metipranolol—Hypersensitivity—Vinblastine—lung cancer	0.00297	0.00299	CcSEcCtD
Metipranolol—Cough—Irinotecan—lung cancer	0.00296	0.00298	CcSEcCtD
Metipranolol—Acute coronary syndrome—Docetaxel—lung cancer	0.00295	0.00298	CcSEcCtD
Metipranolol—Myocardial infarction—Docetaxel—lung cancer	0.00294	0.00296	CcSEcCtD
Metipranolol—Hypertension—Irinotecan—lung cancer	0.00292	0.00295	CcSEcCtD
Metipranolol—Abnormal vision—Doxorubicin—lung cancer	0.00292	0.00294	CcSEcCtD
Metipranolol—Conjunctivitis—Docetaxel—lung cancer	0.00291	0.00294	CcSEcCtD
Metipranolol—Vision blurred—Cisplatin—lung cancer	0.0029	0.00292	CcSEcCtD
Metipranolol—Asthenia—Vinblastine—lung cancer	0.00289	0.00292	CcSEcCtD
Metipranolol—Hypersensitivity—Topotecan—lung cancer	0.00289	0.00291	CcSEcCtD
Metipranolol—Cough—Gemcitabine—lung cancer	0.00288	0.0029	CcSEcCtD
Metipranolol—Discomfort—Irinotecan—lung cancer	0.00285	0.00287	CcSEcCtD
Metipranolol—Hypertension—Gemcitabine—lung cancer	0.00285	0.00287	CcSEcCtD
Metipranolol—Epistaxis—Docetaxel—lung cancer	0.00283	0.00285	CcSEcCtD
Metipranolol—Asthenia—Topotecan—lung cancer	0.00281	0.00283	CcSEcCtD
Metipranolol—Myalgia—Gemcitabine—lung cancer	0.00281	0.00283	CcSEcCtD
Metipranolol—Asthenia—Erlotinib—lung cancer	0.00278	0.0028	CcSEcCtD
Metipranolol—Discomfort—Gemcitabine—lung cancer	0.00278	0.0028	CcSEcCtD
Metipranolol—Oedema—Irinotecan—lung cancer	0.00276	0.00279	CcSEcCtD
Metipranolol—Tension—Paclitaxel—lung cancer	0.00271	0.00273	CcSEcCtD
Metipranolol—Rhinitis—Docetaxel—lung cancer	0.0027	0.00272	CcSEcCtD
Metipranolol—Oedema—Gemcitabine—lung cancer	0.00269	0.00271	CcSEcCtD
Metipranolol—Nervousness—Paclitaxel—lung cancer	0.00268	0.0027	CcSEcCtD
Metipranolol—Dizziness—Vinblastine—lung cancer	0.00267	0.00269	CcSEcCtD
Metipranolol—Myalgia—Cisplatin—lung cancer	0.00262	0.00264	CcSEcCtD
Metipranolol—Anxiety—Cisplatin—lung cancer	0.00261	0.00263	CcSEcCtD
Metipranolol—Vision blurred—Paclitaxel—lung cancer	0.0026	0.00262	CcSEcCtD
Metipranolol—Visual impairment—Docetaxel—lung cancer	0.00259	0.00261	CcSEcCtD
Metipranolol—Dizziness—Topotecan—lung cancer	0.00259	0.00261	CcSEcCtD
Metipranolol—Discomfort—Cisplatin—lung cancer	0.00259	0.00261	CcSEcCtD
Metipranolol—Dizziness—Erlotinib—lung cancer	0.00256	0.00258	CcSEcCtD
Metipranolol—Headache—Vinblastine—lung cancer	0.00253	0.00255	CcSEcCtD
Metipranolol—Oedema—Cisplatin—lung cancer	0.00251	0.00253	CcSEcCtD
Metipranolol—Rash—Topotecan—lung cancer	0.00247	0.00249	CcSEcCtD
Metipranolol—Hypersensitivity—Vinorelbine—lung cancer	0.00247	0.00249	CcSEcCtD
Metipranolol—Dermatitis—Topotecan—lung cancer	0.00247	0.00249	CcSEcCtD
Metipranolol—Dyspnoea—Irinotecan—lung cancer	0.00246	0.00248	CcSEcCtD
Metipranolol—Cough—Etoposide—lung cancer	0.00246	0.00248	CcSEcCtD
Metipranolol—Somnolence—Irinotecan—lung cancer	0.00246	0.00248	CcSEcCtD
Metipranolol—Headache—Topotecan—lung cancer	0.00245	0.00247	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00245	0.00247	CcSEcCtD
Metipranolol—Rash—Erlotinib—lung cancer	0.00244	0.00246	CcSEcCtD
Metipranolol—Dermatitis—Erlotinib—lung cancer	0.00244	0.00246	CcSEcCtD
Metipranolol—Palpitations—Paclitaxel—lung cancer	0.00244	0.00246	CcSEcCtD
Metipranolol—Hypertension—Etoposide—lung cancer	0.00243	0.00245	CcSEcCtD
Metipranolol—Headache—Erlotinib—lung cancer	0.00243	0.00245	CcSEcCtD
Metipranolol—Cough—Paclitaxel—lung cancer	0.00241	0.00243	CcSEcCtD
Metipranolol—Asthenia—Vinorelbine—lung cancer	0.0024	0.00242	CcSEcCtD
Metipranolol—Dyspnoea—Gemcitabine—lung cancer	0.0024	0.00242	CcSEcCtD
Metipranolol—Nausea—Vinblastine—lung cancer	0.0024	0.00241	CcSEcCtD
Metipranolol—Somnolence—Gemcitabine—lung cancer	0.00239	0.00241	CcSEcCtD
Metipranolol—Hypertension—Paclitaxel—lung cancer	0.00238	0.0024	CcSEcCtD
Metipranolol—Discomfort—Etoposide—lung cancer	0.00237	0.00239	CcSEcCtD
Metipranolol—Myalgia—Paclitaxel—lung cancer	0.00235	0.00237	CcSEcCtD
Metipranolol—Anxiety—Paclitaxel—lung cancer	0.00234	0.00236	CcSEcCtD
Metipranolol—Nausea—Topotecan—lung cancer	0.00233	0.00235	CcSEcCtD
Metipranolol—Discomfort—Paclitaxel—lung cancer	0.00232	0.00234	CcSEcCtD
Metipranolol—Nausea—Erlotinib—lung cancer	0.0023	0.00232	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00229	0.0023	CcSEcCtD
Metipranolol—Oedema—Paclitaxel—lung cancer	0.00225	0.00227	CcSEcCtD
Metipranolol—Dyspnoea—Cisplatin—lung cancer	0.00224	0.00226	CcSEcCtD
Metipranolol—Dizziness—Vinorelbine—lung cancer	0.00222	0.00223	CcSEcCtD
Metipranolol—Rash—Vinorelbine—lung cancer	0.00211	0.00213	CcSEcCtD
Metipranolol—Dermatitis—Vinorelbine—lung cancer	0.00211	0.00213	CcSEcCtD
Metipranolol—Headache—Vinorelbine—lung cancer	0.0021	0.00212	CcSEcCtD
Metipranolol—Conjunctivitis—Methotrexate—lung cancer	0.0021	0.00212	CcSEcCtD
Metipranolol—Palpitations—Docetaxel—lung cancer	0.00207	0.00209	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00205	0.00207	CcSEcCtD
Metipranolol—Dyspnoea—Etoposide—lung cancer	0.00205	0.00207	CcSEcCtD
Metipranolol—Somnolence—Etoposide—lung cancer	0.00204	0.00206	CcSEcCtD
Metipranolol—Cough—Docetaxel—lung cancer	0.00204	0.00206	CcSEcCtD
Metipranolol—Angina pectoris—Doxorubicin—lung cancer	0.00204	0.00206	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—lung cancer	0.00204	0.00205	CcSEcCtD
Metipranolol—Hypersensitivity—Irinotecan—lung cancer	0.00204	0.00205	CcSEcCtD
Metipranolol—Atenolol—ABCB1—lung cancer	0.00204	0.261	CrCbGaD
Metipranolol—Hypertension—Docetaxel—lung cancer	0.00202	0.00204	CcSEcCtD
Metipranolol—Bronchitis—Doxorubicin—lung cancer	0.00202	0.00203	CcSEcCtD
Metipranolol—Dyspnoea—Paclitaxel—lung cancer	0.00201	0.00203	CcSEcCtD
Metipranolol—Somnolence—Paclitaxel—lung cancer	0.002	0.00202	CcSEcCtD
Metipranolol—Myalgia—Docetaxel—lung cancer	0.00199	0.00201	CcSEcCtD
Metipranolol—Nausea—Vinorelbine—lung cancer	0.00199	0.00201	CcSEcCtD
Metipranolol—Asthenia—Irinotecan—lung cancer	0.00198	0.002	CcSEcCtD
Metipranolol—Asthenia—Gemcitabine—lung cancer	0.00193	0.00195	CcSEcCtD
Metipranolol—Oedema—Docetaxel—lung cancer	0.00191	0.00193	CcSEcCtD
Metipranolol—Acebutolol—ABCB1—lung cancer	0.00188	0.241	CrCbGaD
Metipranolol—Visual impairment—Methotrexate—lung cancer	0.00187	0.00188	CcSEcCtD
Metipranolol—Hypersensitivity—Cisplatin—lung cancer	0.00185	0.00186	CcSEcCtD
Metipranolol—Dizziness—Irinotecan—lung cancer	0.00183	0.00184	CcSEcCtD
Metipranolol—Conjunctivitis—Doxorubicin—lung cancer	0.00182	0.00183	CcSEcCtD
Metipranolol—Asthenia—Cisplatin—lung cancer	0.0018	0.00181	CcSEcCtD
Metipranolol—Epistaxis—Doxorubicin—lung cancer	0.00176	0.00178	CcSEcCtD
Metipranolol—Rash—Irinotecan—lung cancer	0.00174	0.00176	CcSEcCtD
Metipranolol—Dermatitis—Irinotecan—lung cancer	0.00174	0.00175	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00174	0.00175	CcSEcCtD
Metipranolol—Headache—Irinotecan—lung cancer	0.00173	0.00175	CcSEcCtD
Metipranolol—Bradycardia—Doxorubicin—lung cancer	0.00171	0.00172	CcSEcCtD
Metipranolol—Dyspnoea—Docetaxel—lung cancer	0.0017	0.00172	CcSEcCtD
Metipranolol—Somnolence—Docetaxel—lung cancer	0.0017	0.00171	CcSEcCtD
Metipranolol—Rash—Gemcitabine—lung cancer	0.0017	0.00171	CcSEcCtD
Metipranolol—Dermatitis—Gemcitabine—lung cancer	0.0017	0.00171	CcSEcCtD
Metipranolol—Hypersensitivity—Etoposide—lung cancer	0.00169	0.00171	CcSEcCtD
Metipranolol—Headache—Gemcitabine—lung cancer	0.00169	0.0017	CcSEcCtD
Metipranolol—Rhinitis—Doxorubicin—lung cancer	0.00168	0.0017	CcSEcCtD
Metipranolol—Hypersensitivity—Paclitaxel—lung cancer	0.00166	0.00167	CcSEcCtD
Metipranolol—Asthenia—Etoposide—lung cancer	0.00165	0.00166	CcSEcCtD
Metipranolol—Nausea—Irinotecan—lung cancer	0.00164	0.00165	CcSEcCtD
Metipranolol—Visual impairment—Doxorubicin—lung cancer	0.00162	0.00163	CcSEcCtD
Metipranolol—Asthenia—Paclitaxel—lung cancer	0.00162	0.00163	CcSEcCtD
Metipranolol—Nausea—Gemcitabine—lung cancer	0.0016	0.00161	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—lung cancer	0.00159	0.0016	CcSEcCtD
Metipranolol—Metoprolol—ABCB1—lung cancer	0.00159	0.203	CrCbGaD
Metipranolol—Rash—Cisplatin—lung cancer	0.00158	0.00159	CcSEcCtD
Metipranolol—Dermatitis—Cisplatin—lung cancer	0.00158	0.00159	CcSEcCtD
Metipranolol—Dizziness—Etoposide—lung cancer	0.00152	0.00153	CcSEcCtD
Metipranolol—Propranolol—CYP1A1—lung cancer	0.00151	0.193	CrCbGaD
Metipranolol—Dizziness—Paclitaxel—lung cancer	0.00149	0.0015	CcSEcCtD
Metipranolol—Nausea—Cisplatin—lung cancer	0.00149	0.0015	CcSEcCtD
Metipranolol—Cough—Methotrexate—lung cancer	0.00147	0.00148	CcSEcCtD
Metipranolol—Rash—Etoposide—lung cancer	0.00145	0.00146	CcSEcCtD
Metipranolol—Dermatitis—Etoposide—lung cancer	0.00145	0.00146	CcSEcCtD
Metipranolol—Headache—Etoposide—lung cancer	0.00144	0.00145	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—lung cancer	0.00144	0.00145	CcSEcCtD
Metipranolol—Tension—Doxorubicin—lung cancer	0.00143	0.00145	CcSEcCtD
Metipranolol—Rash—Paclitaxel—lung cancer	0.00142	0.00143	CcSEcCtD
Metipranolol—Dermatitis—Paclitaxel—lung cancer	0.00142	0.00143	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—lung cancer	0.00142	0.00143	CcSEcCtD
Metipranolol—Nervousness—Doxorubicin—lung cancer	0.00142	0.00143	CcSEcCtD
Metipranolol—Headache—Paclitaxel—lung cancer	0.00141	0.00142	CcSEcCtD
Metipranolol—Hypersensitivity—Docetaxel—lung cancer	0.00141	0.00142	CcSEcCtD
Metipranolol—Vision blurred—Doxorubicin—lung cancer	0.00138	0.00139	CcSEcCtD
Metipranolol—Asthenia—Docetaxel—lung cancer	0.00137	0.00138	CcSEcCtD
Metipranolol—Nausea—Etoposide—lung cancer	0.00137	0.00138	CcSEcCtD
Metipranolol—Nausea—Paclitaxel—lung cancer	0.00134	0.00135	CcSEcCtD
Metipranolol—Palpitations—Doxorubicin—lung cancer	0.00129	0.0013	CcSEcCtD
Metipranolol—Cough—Doxorubicin—lung cancer	0.00128	0.00129	CcSEcCtD
Metipranolol—Dizziness—Docetaxel—lung cancer	0.00126	0.00127	CcSEcCtD
Metipranolol—Hypertension—Doxorubicin—lung cancer	0.00126	0.00127	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00125	0.00126	CcSEcCtD
Metipranolol—Myalgia—Doxorubicin—lung cancer	0.00124	0.00125	CcSEcCtD
Metipranolol—Anxiety—Doxorubicin—lung cancer	0.00124	0.00125	CcSEcCtD
Metipranolol—Discomfort—Doxorubicin—lung cancer	0.00123	0.00124	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—lung cancer	0.00123	0.00124	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—lung cancer	0.00122	0.00123	CcSEcCtD
Metipranolol—Rash—Docetaxel—lung cancer	0.0012	0.00121	CcSEcCtD
Metipranolol—Dermatitis—Docetaxel—lung cancer	0.0012	0.00121	CcSEcCtD
Metipranolol—Headache—Docetaxel—lung cancer	0.0012	0.00121	CcSEcCtD
Metipranolol—Oedema—Doxorubicin—lung cancer	0.00119	0.0012	CcSEcCtD
Metipranolol—Nausea—Docetaxel—lung cancer	0.00113	0.00114	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00109	0.0011	CcSEcCtD
Metipranolol—Dyspnoea—Doxorubicin—lung cancer	0.00106	0.00107	CcSEcCtD
Metipranolol—Somnolence—Doxorubicin—lung cancer	0.00106	0.00107	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—lung cancer	0.00101	0.00102	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—lung cancer	0.000988	0.000996	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—lung cancer	0.000911	0.000918	CcSEcCtD
Metipranolol—Hypersensitivity—Doxorubicin—lung cancer	0.000879	0.000886	CcSEcCtD
Metipranolol—Rash—Methotrexate—lung cancer	0.000868	0.000875	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—lung cancer	0.000868	0.000874	CcSEcCtD
Metipranolol—Headache—Methotrexate—lung cancer	0.000863	0.00087	CcSEcCtD
Metipranolol—Asthenia—Doxorubicin—lung cancer	0.000856	0.000862	CcSEcCtD
Metipranolol—Nausea—Methotrexate—lung cancer	0.000818	0.000824	CcSEcCtD
Metipranolol—Propranolol—ABCB1—lung cancer	0.0008	0.103	CrCbGaD
Metipranolol—Dizziness—Doxorubicin—lung cancer	0.000789	0.000795	CcSEcCtD
Metipranolol—Rash—Doxorubicin—lung cancer	0.000752	0.000758	CcSEcCtD
Metipranolol—Dermatitis—Doxorubicin—lung cancer	0.000751	0.000757	CcSEcCtD
Metipranolol—Headache—Doxorubicin—lung cancer	0.000747	0.000753	CcSEcCtD
Metipranolol—Nausea—Doxorubicin—lung cancer	0.000708	0.000714	CcSEcCtD
